---

title: Pyrrolo[2,3-B]pyridine CDK9 kinase inhibitors
abstract: 

wherein R, R, R, X, X, X, X, X, have any of the values defined therefore in the specification, and pharmaceutically acceptable salts thereof. The compounds may be used as agents in the treatment of diseases, including cancer. Also provided are pharmaceutical compositions comprising one or more compounds of Formula (IIIa).

url: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=1&f=G&l=50&d=PALL&S1=09073922&OS=09073922&RS=09073922
owner: AbbVie, Inc.
number: 09073922
owner_city: North Chicago
owner_country: US
publication_date: 20140313
---
